Loading...

Qiagen N.V.

QGEN•NYSE
Healthcare
Medical - Diagnostics & Research
$48.89
$-0.85(-1.71%)

Qiagen N.V. (QGEN) Stock Overview

Explore Qiagen N.V.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 71.8/100

Key Financials

Market Cap10.6B
P/E Ratio28.40
EPS (TTM)$1.71
ROE0.11%
Fundamental Analysis

AI Price Forecasts

1 Week$47.26
1 Month$41.47
3 Months$44.61
1 Year Target$46.19

QGEN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Qiagen N.V. (QGEN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 48.65, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $46.19.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 28.40 and a market capitalization of 10.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-3.28%
5-Day Change
1.16%
1-Month Change
3.03%
3-Month Change
-12.82%
6-Month Change
-10.00%
Year-to-Date (YTD) Change
-12.49%
1-Year Change
-5.41%
3-Year Change
-21.42%
5-Year Change
-4.80%
All-Time (Max) Change
1826.44%

Contact Information

https://www.qiagen.com
31 77 355 6600
Hulsterweg 82, Venlo, 5912 PL

Company Facts

5,700 Employees
IPO DateJun 28, 1996
CountryNL
Actively Trading

Frequently Asked Questions

;